论文部分内容阅读
本文报告3例尿毒症病人接受了父亲或母亲提供的肾脏而行肾移植,移植方式同尸体肾。供肾取自左侧或右侧,术前对供者的肾功能进行系统检查并行肾动脉造影,HLA配型。免疫抑制剂使用与尸体肾大致相同。随访3月～6月。结果表明3例供体围手术期平稳渡过,9～10天出院,复查肾功能各项指标均未发现异常,现已恢复正常生活、工作。3例受者均于开放肾血流后2min内泌尿,2例术后3天内血肌酐达正常水平,肌酐清除率3周时80ml/min;1例术后当天出现短暂肾功能延迟,术后1周血肌酐达正常值,3周时肌酐清除率60ml/min。因而认为亲属活体肾移植供体是安全的,且生存质量良好。受者肾功能恢复快,质量稳定。亲属供肾扩大了肾源,可选择性实施。
This article reports 3 cases of uremic patients accepted the kidney provided by the father or mother and kidney transplant, transplantation with the body of kidney. The kidneys were taken from the left or the right, and the renal function of the donor was systematically examined before operation, and renal artery angiography and HLA matching were performed. Immunosuppressants are used in much the same way as cadaveric kidneys. Follow-up from March to June. The results showed that 3 donors had a smooth perioperative period and were discharged from 9 to 10 days. No abnormalities were found in the indexes of renal function, and their normal life and work were resumed. Three of them received urinary excretion within 2 minutes after open renal blood flow, two had normal serum creatinine within 3 days after operation, and a creatinine clearance rate of 80 ml / min at 3 weeks. One patient had a transient renal function delay on the day after operation, 1 week serum creatinine up to normal, creatinine clearance 3 weeks 60ml / min. So that relatives living donor kidney transplant donor is safe, and good quality of life. Recipient rapid recovery of renal function, quality and stability. Relatives kidney enlargement of the kidney, can be selectively implemented.